Stabilizing progressive vitiligo with systemic treatment

Published: 31 May 2024| Version 2 | DOI: 10.17632/mgk5526yw2.2
Contributors:
Ting-Ting Yang,

Description

This study evaluates the clinical features of vitiligo patients requiring prolonged or multiple courses of systemic immunosuppressants to control disease activity.

Files

Categories

Dermatology, Vitiligo

Licence